PharmaLink Conference

项目摘要 PharmaLink会议的主要目标是： 与FDA和行业开放合作和参与，讨论制药挑战， 机会 为制药行业和整个医疗保健领域的新兴问题确定创新解决方案。 AFDO建议PhamaLink会议计划遵循以下格式： 在2023-2024年期间，将举办一次现场会议，介绍和促进 讨论如何确定和建立创新的协作解决办法， 制药行业，以推进病人护理。 在每次会议期间，来自行业各个领域的130多位制药领导人将出席 共同围绕合作机会中出现的问题进行创新， 行业和监管机构。

Project Summary The key objectives of the PharmaLink Conference are:  Open collaboration and engagement with FDA and industry to discuss pharmaceutical challenges and opportunities.  Identify innovative solutions for rising issues in the pharmaceutical industry and across healthcare. AFDO proposes the PhamaLink Conference plan to follow this format:  During years 2023-2024 there will be an in-person conference with presentations and facilitated discussions on identifying and building innovative and collaborative solutions to be used in the pharmaceutical industry to advance patient care. During each conference, a group of 130+ Pharmaceutical leaders from all areas of the industry will come together to lead innovation around the issues surfaced during the collaborative opportunities between industry and regulators.